Overview
Availability
- Professor Scott Bell is:
- Available for supervision
Fields of research
Works
Search Professor Scott Bell’s works on UQ eSpace
2006
Conference Publication
Pharmacokinetic study of itraconazole leads to new improved dosing regimens for paediatric cystic fibrosis and bone marrow transplant patients
Hennig, S, Wainwright, C E, Bell, S, Miller, H, Friberg, L. E. and Charles, B G (2006). Pharmacokinetic study of itraconazole leads to new improved dosing regimens for paediatric cystic fibrosis and bone marrow transplant patients. The 6th Annual Health and Medical Research Conference of Queensland, Brisbane, Australia, 23-24 November 2006. Brisbane, Australia: Queensland Health.
2006
Conference Publication
A D-optimal designed population pharmacokinetic study of itraconazole capsules and solution in adults with cystic fibrosis
Hennig, S., Wainwright, C. E., Bell, S., Miller, H., Charles, B. G. and Duffull, S. B. (2006). A D-optimal designed population pharmacokinetic study of itraconazole capsules and solution in adults with cystic fibrosis. 15th Annual Meeting of the Population Approach Group in Europe, Bruges, Belgium, 14-16 June 2006. PAGE.
2006
Journal Article
Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients
Hennig, S., Wainwright, C. E., Bell, S. C., Miller, H., Friberg, L. E. and Charles, B. G. (2006). Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients. Clinical Pharmacokinetics, 45 (11), 1099-1114. doi: 10.2165/00003088-200645110-00004
2006
Conference Publication
Paediatric population pharmacokinetcis (popPK) of itraconazole (ITRA) and its active metabolite hydroxy-itraconazole in cystic fibrosis (CF) and bone marrow transplant patients (BMT)
Hennig, S, Wainwright, C E, Bell, S, Miller, H, Friberg, L. E. and Charles, B G (2006). Paediatric population pharmacokinetcis (popPK) of itraconazole (ITRA) and its active metabolite hydroxy-itraconazole in cystic fibrosis (CF) and bone marrow transplant patients (BMT). PAGANZ 06 9th Annual Scientific Meeting, Auckland New Zealand / School of Medicine, 7-9 February 2006. Brisbane, Australia: Poppulation Approach Group in Australia and New Zealand.
2006
Book Chapter
Cystic Fibrosis Infection with Clonal Strains of Pseudomonas Aeruginosa: Current Knowledge and Future Management
Jones, A. M. and Bell, S. C. (2006). Cystic Fibrosis Infection with Clonal Strains of Pseudomonas Aeruginosa: Current Knowledge and Future Management. Cystic Fibrosis. (pp. 105-126) edited by K. Webb and F. Ratjen. London: Maney Publishing.
2006
Conference Publication
Paediatric population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in cystic fibrosis and bone marrow transplant patients
Hennig, S., Wainwright, C. E., Bell, S. C., Miller, H., Friberg, L. E. and Charles, B. G. (2006). Paediatric population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in cystic fibrosis and bone marrow transplant patients. Population Approach Group Europe: 15th Meeting, Bruges, Belgium, 14-16 June 2006. PAGE.
2005
Journal Article
Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions
Hill, Dominic, Rose, Barbara, Pajkos, Aniko, Robinson, Michael, Bye, Peter, Bell, Scott C., Elkins, Mark, Thompson, Barbara, MacLeod, Colin, Aaron, Shawn D. and Harbour, Colin (2005). Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. Journal of Clinical Microbiology, 43 (10), 5085-5090. doi: 10.1128/JCM.43.10.5085-5090.2005
2005
Journal Article
MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?
Downey, D. G., Kidd, T. J., Coulter, C. and Bell, S. C. (2005). MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?. Journal of Cystic Fibrosis, 4 (3), 205-207. doi: 10.1016/j.jcf.2005.05.014
2005
Journal Article
Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosis
Buntain, Helen M., Greer, Ristan M., Wong, Joseph C.H., Schluter, Philip J., Batch, Jennifer, Lewindon, Peter, Bell, Scott C. and Wainwright, Claire E. (2005). Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosis. Journal of Paediatrics And Child Health, 41 (7), 317-322. doi: 10.1111/j.1440-1754.2005.00635.x
2005
Journal Article
Has the time come to prescribe azithromycin in cystic fibrosis patients?
McCormack, J. G. and Bell, S. C. (2005). Has the time come to prescribe azithromycin in cystic fibrosis patients?. Internal Medicine Journal, 35 (2), 73-74. doi: 10.1111/j.1445-5994.2004.00762.x
2005
Conference Publication
Antibiotics for acute exacerbations of COPD: A systematic review
Yang, I. A., Kim, S. T. and Bell, S. C. (2005). Antibiotics for acute exacerbations of COPD: A systematic review. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1
2005
Conference Publication
The effect of mucoidy on biofilm formation in cystic fibrosis clinical isolates
Semple, K., Senini, S., Serisier, D., Bowler, S., Bell, S. and McCormack, J. (2005). The effect of mucoidy on biofilm formation in cystic fibrosis clinical isolates. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1
2005
Conference Publication
A study of desensitisation procedures to beta-lactam antibiotics in adult patients with cystic fibrosis: An update
Burrows, J., Nissen, L. M., Kirkpatrick, C. M. J. and Bell, S. C. (2005). A study of desensitisation procedures to beta-lactam antibiotics in adult patients with cystic fibrosis: An update. Sixth Australian & New Zealand Cystic Fibrosis Conference, Adelaide, 20-23 Aug. 2005. Australia:
2005
Conference Publication
Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotype
Kim, S. T., Passmore, L., Dent, A. G., Slaughter, R., Yang, I. A., Fong, K. M., Zimmerman, P. V. and Bell, S. C. (2005). Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotype. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1
2005
Conference Publication
Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis
Kermeen, F. D., Kim, S. T., Kidd, T. J., Coulter, C., Greer, R. M. and Bell, S. C. (2005). Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis. 28th European Cystic Fibrosis Conference, Crete, Greece, 22-25 June 2005. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/S1569-1993(05)80113-4
2005
Journal Article
Macrolides in cystic fibrosis
Bell, S. C., Senini, S. L. and McCormack, J. G. (2005). Macrolides in cystic fibrosis. Chronic Respiratory Disease, 2 (2), 85-98. doi: 10.1191/1479972305cd066rs
2005
Conference Publication
Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis
Kermeen, F. D., Kim, S. T., Kidd, T. J., Coulter, C., Greer, R. M. and Bell, S. C. (2005). Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, WA, Australia, 18-23 March 2005. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1
2005
Conference Publication
Antibiotics in cystic fibrosis (CF): A systematic review
Kim, S. T., Yang, I. A. and Bell, S. C. (2005). Antibiotics in cystic fibrosis (CF): A systematic review. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1
2005
Conference Publication
Antibiotics in cystic fibrosis (CF): A systematic review
Kim, S. T., Yang, I. A. and Bell, S. C. (2005). Antibiotics in cystic fibrosis (CF): A systematic review. Array, Crete, Greece, 22-25 Jun, 2005. Amsterdam, Netherlands: Elsevier BV.
2005
Journal Article
Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multi-resistant bacteria: A randomised, double-blind, controlled clinical trial
Aaron, Shawn D., Vandemheen, Katherine L., Ferris, Wendy, Fergusson, Dean, Tullis, Elizabeth, Haase, David, Berthiaume, Yves, Brown, Neil, Wilcox, Pearce, Yozghatlian, Veronica, Bye, Peter, Bell, Scott, Chan, Francis, Rose, Barbara, Jeanneret, Alphonse, Stephenson, Anne, Noseworthy, Mary, Freitag, Andreas, Paterson, Nigel, Doucette, Steve, Harbour, Colin, Ruel, Michel and MacDonald, Noni (2005). Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multi-resistant bacteria: A randomised, double-blind, controlled clinical trial. The Lancet, 366 (9484), 463-471. doi: 10.1016/S0140-6736(05)67060-2
Funding
Current funding
Supervision
Availability
- Professor Scott Bell is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Risk and mitigation of cough aerosols for people with cystic fibrosis.
Principal Advisor
Other advisors: Professor Rachel Thomson
-
Doctor Philosophy
Risk and mitigation of cough aerosols for people with cystic fibrosis.
Principal Advisor
Other advisors: Professor Rachel Thomson
-
Doctor Philosophy
Pharmacokinetics of anti-mycobacterial drugs in patients with cystic fibrosis
Associate Advisor
Other advisors: Professor Rachel Thomson, Professor Jason Roberts
Completed supervision
-
2019
Master Philosophy
Infectious airborne transport in individuals with cystic fibrosis and mitigation strategies to reduce aerosol dispersal
Principal Advisor
-
2019
Doctor Philosophy
Impact of built environment, personal protective devices and ventilation on the dispersion of respiratory pathogens
Principal Advisor
-
2018
Doctor Philosophy
Diversity of environmental and clinical Pseudomonas aeruginosa isolates
Principal Advisor
Other advisors: Associate Professor David Whiley
-
2016
Doctor Philosophy
Heterogeneity within Pseudomonas aeruginosa shared strains in cystic fibrosis: the development and spread of antimicrobial resistance
Principal Advisor
Other advisors: Associate Professor David Whiley
-
2012
Doctor Philosophy
Diagnosis, epidemiology and population structure of Pseudomonas aeruginosa in cystic fibrosis.
Principal Advisor
-
2022
Doctor Philosophy
The effectiveness of ultraviolet C light at inactivating airborne Pseudomonas aeruginosa and Mycobacterium abscessus
Associate Advisor
-
2022
Doctor Philosophy
Deep Sequencing of Microbial Communities in Cystic Fibrosis Airways
Associate Advisor
Other advisors: Professor Ian Henderson
Media
Enquiries
For media enquiries about Professor Scott Bell's areas of expertise, story ideas and help finding experts, contact our Media team: